Annual Revenue ($)

Pfizer revenue was $52.55 b in FY, 2017 which is a 0.5% year over year decrease from the previous period.

Quarterly Revenue ($)

FY, 2015FY, 2016FY, 2017
Revenue$48.85 b$52.82 b$52.55 b
Growth(1.52%)8.13%(0.53%)
Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018
Revenue$13.01 b$13.15 b$13.05 b$12.78 b$12.90 b$13.17 b$12.91 b$13.47 b$13.30 b
Report incorrect company information

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Pfizer revenue breakdown by business segment: 59.8% from Innovative Health and 40.2% from Essential Health

Pfizer revenue breakdown by geographic segment: 21.7% from Emerging Markets, 12.6% from Developed Rest of World, 16.2% from Developed Europe and 49.5% from United States

FY, 2015FY, 2016FY, 2017
Innovative Health26.76 b29.20 b31.42 b
Essential Health22.09 b23.63 b21.12 b
FY, 2015FY, 2016FY, 2017
Emerging Markets11.14 b10.42 b11.40 b
Developed Rest of World6.30 b6.73 b6.61 b
Developed Europe9.71 b9.31 b8.51 b
United States21.70 b26.37 b26.03 b
Report incorrect company information